Computed Tomography, Magnetic Resonance Imaging, and Pathological Features of Gliosarcoma

References

• Dardis C, Donner D, Sanai N, et al. Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling [published correction appears in BMC Neurol. 2021 Aug 14; 2 1):316]. BMC Neurol. 2021;21(1):231. doi:10.1186/s12883-021-02233-5
   Web of Science ®Google Scholar
• Zaki MM, Mashouf LA, Woodward E, et al. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021;11(1):18009. doi:10.1038/s41598-021-97454-6
   Web of Science ®Google Scholar
• Frandsen J, Orton A, Jensen R, et al. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database. J Neurosurg. 2018;128(4):1133–1138. doi:10.3171/2016.12.JNS162291
   Web of Science ®Google Scholar
• Yi X, Cao H, Tang H, et al. Gliosarcoma: a clinical and radiological analysis of 48 cases. Eur Radiol. 2019;29(1):429–438. doi:10.1007/s00330-018-5398-y
   Web of Science ®Google Scholar
• Feng SS, Li HB, Fan F, et al. Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis. Sci Rep. 2019;9(1):10744. doi:10.1038/s41598-019-47211-7
   Web of Science ®Google Scholar
• Qian Z, Zhang L, Hu J, et al. Machine learning-based analysis of magnetic resonance radiomics for the classification of gliosarcoma and glioblastoma. Front Oncol. 2021;11:699789. doi:10.3389/fonc.2021.699789
   Web of Science ®Google Scholar
• Awadalla AS, Al Essa AM, Al Ahmadi HH, et al. Gliosarcoma case report and review of the literature. Pan Afr Med J. 2020;35:26. doi:10.11604/pamj.2020.35.26.17577
   Web of Science ®Google Scholar
• Doddamani RS, Meena RK, Selvam MM, et al. Intraventricular gliosarcomas: literature review and a case description. World Neurosurg. 2016;90:707.e5–707.e12. doi:10.1016/j.wneu.2016.03.033
   Web of Science ®Google Scholar
• Li J, Zhao YH, Tian SF, et al. Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma. CNS Neurosci Ther. 2021;27(12):1483–1492. doi:10.1111/cns.13740
   Web of Science ®Google Scholar
• Ma R, Alexe DM, Pereira EA. Primary gliosarcoma: epidemiology, clinical presentation, management, and survival [published correction appears in J Neurosurg Sci. 2020 Oct;64(5):498]. J Neurosurg Sci. 2020;64(4):341–346. doi:10.23736/S0390-5616.17.04077-2
   Web of Science ®Google Scholar
• Din NU, Ishtiaq H, Rahim S, et al. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature. BMC Pediatr. 2021;21(1):101. doi:10.1186/s12887-021-02556-9
   Web of Science ®Google Scholar
• de Macedo Filho LJM, Barreto EG, Martins PLB, et al. IDH1-mutant primary intraventricular gliosarcoma: case report and systematic review of a rare location and molecular profile. Surg Neurol Int. 2020;11:372. doi:10.25259/SNI_586_2020
   Google Scholar
• Meloni M, Serra S, Bellisano G, et al. Primary gliosarcoma of the cerebellum in a young pregnant woman: management challenges and immunohistochemical features. Case Rep Surg. 2019;2019:7105361. doi:10.1155/2019/7105361
   Web of Science ®Google Scholar
• Sugita Y, Terasaki M, Tanigawa K, et al. Gliosarcomas arising from the pineal gland region: uncommon localization and rare tumors. Neuropathology. 2016;36(1):56–63. doi:10.1111/neup.12226
   Web of Science ®Google Scholar
• Prado RMA, Tamura BP, Gomez GD. Optic pathway gliosarcoma: a very rare location for a rare disease. Radiol Case Rep. 2021;16(7):1665–1668. doi:10.1016/j.radcr.2021.04.001
   Google Scholar
• Shieh LT, Guo HR, Chang YK, et al. Clinical implications of multiple glioblastomas: an analysis of prognostic factors and survival to distinguish from their single counterparts. J Formos Med Assoc. 2020;119(3):728–734. doi:10.1016/j.jfma.2019.08.024
   Web of Science ®Google Scholar
• Zhang Y, Ma JP, Weng JC, et al. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study. Neurosurg Rev. 2021;44(2):1003–1015. doi:10.1007/s10143-020-01285-4
   Web of Science ®Google Scholar
• Meyer RM, Miller CA, Coughlin DJ, et al. Glioblastoma recurrence, progression, and dissemination as a purely subdural gliosarcoma. J Neurooncol. 2017;132(3):521–522. doi:10.1007/s11060-017-2397-9
   Web of Science ®Google Scholar
• Lee J, Rodriguez F, Ali SZ. Metastatic gliosarcoma: cytopathologic characteristics with histopathologic correlations. Acta Cytol. 2016;60(5):490–494. doi:10.1159/000448509
   Google Scholar
• Saadeh F, El Iskandarani S, Najjar M, et al. Prognosis and management of gliosarcoma patients: a review of literature. Clin Neurol Neurosurg. 2019;182:98–103. doi:10.1016/j.clineuro.2019.05.008
   Web of Science ®Google Scholar
• Noch EK, Sait SF, Farooq S, et al. A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center. Neurooncol Pract. 2021;8(3):325–336. doi:10.1093/nop/npaa083
   PubMed Web of Science ®Google Scholar
• Mittal N, Tayal S. Advance computer analysis of magnetic resonance imaging (MRI) for early brain tumor detection. Int J Neurosci. 2021;131(6):555–570. doi:10.1080/00207454.2020.1750390
   PubMed Web of Science ®Google Scholar
• Zhang BY, Chen H, Geng DY, et al. Computed tomography and magnetic resonance features of gliosarcoma: a study of 54 cases. J Comput Assist Tomogr. 2011;35(6):667–673. doi:10.1097/RCT.0b013e3182331128
   Web of Science ®Google Scholar
• Sampaio L, Linhares P, Fonseca J. Detailed magnetic resonance imaging features of a case series of primary gliosarcoma. Neuroradiol J. 2017;30(6):546–553. doi:10.1177/1971400917715879
   Web of Science ®Google Scholar
• Fukuda A, Queiroz LS, Reis F. Gliosarcomas: magnetic resonance imaging findings. Arq Neuropsiquiatr. 2020;78(2):112–120. doi:10.1590/0004-282x20190158
   Web of Science ®Google Scholar
• Kiang KM, Chan AA, Leung GK. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma. BMC Cancer. 2021;21(1):265. doi:10.1186/s12885-021-08008-y
   Web of Science ®Google Scholar
• Romero-Rojas AE, Diaz-Perez JA, Ariza-Serrano LM, Amaro D, Lozano-Castillo A. Primary gliosarcoma of the brain: radiologic and histopathologic features. Neuroradiol J. 2013;26(6):639–648. doi:10.1177/197140091302600606
   Google Scholar
• Farche MK, Fachinetti NO, da Silva LR, et al. Revisiting the use of proton magnetic resonance spectroscopy in distinguishing between primary and secondary malignant tumors of the central nervous system. Neuroradiol J. 2022;35(5):619–626. doi:10.1177/19714009221083145
   Web of Science ®Google Scholar
• Server A, Josefsen R, Kulle B, et al. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol. 2010;51(3):316–325. doi:10.3109/02841850903482901
   Web of Science ®Google Scholar
• Matsumura A, Isobe T, Takano S, et al. Non-invasive quantification of lactate by proton MR spectroscopy and its clinical applications. Clin Neurol Neurosurg. 2005;107(5) :379–384. doi:10.1016/j.clineuro.2004.10.009
   Web of Science ®Google Scholar
• Schwingel R, Reis F, Zanardi VA, et al. Central nervous system lymphoma: magnetic resonance imaging features at presentation. Arq Neuro-Psiquiatr. 2012;70(2):97–101. doi:10.1590/s0004-282x2012000200005
   Web of Science ®Google Scholar
• Srivastava H, Dewan A, Sharma SK, et al. Adjuvant radiation therapy and temozolomide in gliosarcoma: is it enough? Case series of seven patients. Asian J Neurosurg. 2018;13(2):297–301. doi:10.4103/ajns.AJNS_151_16
   Google Scholar
• Smith DR, Wu CC, Saadatmand HJ, et al. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma. J Neurooncol. 2018;137(2):303–311. doi:10.1007/s11060-017-2718-z
   Web of Science ®Google Scholar
• Chen B, Liu B, Wu C, Wang Z. Prognostic factors among single primary gliosarcoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973–2013. Cancer Med. 2019;8(14):6233–6242. doi:10.1002/cam4.2503
   Web of Science ®Google Scholar
• Yoshida Y, Ide M, Fujimaki H, et al. Gliosarcoma with primitive neuronal, chondroid, osteoid and ependymal elements [published online ahead of print, 2018 Mar 5]. Neuropathology. 2018. doi:10.1111/neup.12461
   Web of Science ®Google Scholar
• Acharya UR, Hagiwara Y, Sudarshan VK, et al. Towards precision medicine: from quantitative imaging to radiomics. J Zhejiang Univ Sci B. 2018;19(1):6–24. doi:10.1631/jzus.B1700260
   PubMed Web of Science ®Google Scholar